Highlights from the AAD 2013, Miami: Advances in Melanoma

An exciting talk from this year’s American Academy of Dermatology Meeting (AAD 2013) in Miami was the annual Marion B. Sulzberger Memorial Award and Lectureship given by Dr. Hensin Tsao.  Dr. Tsao talked about “Melanoma and Its Metaphors,” drawing parallels between the machinery behind melanoma to the machinery behind cars.  While problems can arise with cars, so can the biological machinery that drives cells to go out of control and develop into melanoma.  Dr. Tsao discussed tumor suppressor and proto-oncogenes.  Likening them to faulty brake systems, Dr. Tsao discussed how tumor suppressor genes are like the brakes in cells, and when messed up, the cell keeps going, dividing out of control.  On the other hand, if the accelerator of the car gets stuck in the down position, the car keeps going as well. Proto-oncogenes, or oncogenes, are accelerators of melanoma.

In the realm of melanoma therapy, we’ve made some great strides in directed therapy.  Among these are the drugs that target a very specific mutation that 60% of melanomas have (the V600E mutation).  These are drugs like vemurafenib and dabrafenib.  Although some of the tumors then find ways around these drugs when given alone, researchers and physicians have then added an additional drug, tramatenib (a MEK inhibitor) to the cocktail.  Two hits against the melanoma!  And there’s even more exciting stuff to come.

In short, in these past few years, we have seen major advances in melanoma therapy and I hope that with the direction we’re going, we’ll be able to put a permanent halt to melanoma!

Highlights from the AAD 2013 in Miami

Alas, the 2013 annual meeting of the American Academy of Dermatology is nearing its close.  It’s been a great 4 days in Miami — albeit a little colder and cloudier than expected, but hey, we’re all indoors enjoying the sessions anyways right?

courtesy of Flickr user ceiling
courtesy of Flickr user ceiling

After a jam-packed schedule, I now have a little bit of time to give you an update on the meeting.

This has been an exciting year in dermatology and yesterday’s Plenary Session attested to that.  Dr. Daniel Siegel gave remarks as his term draws to a close and as Dr. Dirk Elston  looks towards his incoming presidency of the AAD. Dr. Siegel remarked on some of the challenges that we have as dermatologists as the government continues to look at the proper way of reimbursements for all of medicine including dermatology.  Dr. Siegel was optimistic about his forecast for the  coming years of dermatology, predicting advances in science and technology which would allow for personalized treatment for the deadly cancer melanoma and “biopsies” without having to cut the skin.  He also called for us to continue to work together as a group as dermatologists continue to be the expert group that provides skin care.

It’s been an exciting year under Dr. Siegel’s direction, and of course, we will always remember his getting his head shaved at the Summer AAD in Boston afterSkinPAC raised more than 1 million dollars!